Vertex Pharmaceuticals Incorporated
Boston, MA
- UEI
- Y4NLRU471XL7
- CAGE
- 4LQG8
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 50 Northern Ave, Boston, MA 02210, USA
- Website
- vrtx.com
- Founded
- 1989
- Employees
- 1K-5K
- Estimated annual revenue
- $1B-$10B
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract vehicles
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Phase 2 study of VX-770 in cystic fibrosis subjectswith G551D | Food and Drug Administration | $350,000 | |
| Identification of novel immunosuppresive agents | National Institutes of Health | $182,158 |
Quick answers
Is Vertex Pharmaceuticals Incorporated registered in SAM.gov?
Yes. Vertex Pharmaceuticals Incorporated's SAM.gov registration is active through December 17, 2026.
What is Vertex Pharmaceuticals Incorporated's CAGE code?
Vertex Pharmaceuticals Incorporated's CAGE code is 4LQG8, and its Unique Entity ID (UEI) is Y4NLRU471XL7.
Which contract vehicles does Vertex Pharmaceuticals Incorporated hold?
Vertex Pharmaceuticals Incorporated holds a place on 1 federal contract vehicle: FSS-61-IB.
What is Vertex Pharmaceuticals Incorporated's most recent federal award?
Vertex Pharmaceuticals Incorporated's most recent federal grant award is Phase 2 study of VX-770 in cystic fibrosis subjectswith G551D (R01FD003432), from Food and Drug Administration, on September 30, 2007.
On GovTribe
See Vertex Pharmaceuticals Incorporated's full federal record
- IDV awards
- Contract vehicles
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors